Aethlon Medical, Inc.

  • Home
  • The Hemopurifier®
    • The Hemopurifier® in Infectious Disease
    • The Hemopurifier® in Cancer
    • Resources
  • About
    • Overview
    • Exosome Sciences, Inc.
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Contact Us
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Outside Media
  • Investors
    • Overview
    • Corporate News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • IRS Form 8937
Investors

Investors

  • Overview
  • Corporate News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Profile
    • Presentations
    • Executive Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Governance Documents
  • IRS Form 8937
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

Press Releases

  • Corporate News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Mar 1, 2021

Aethlon Medical to Participate in Two Upcoming Healthcare Investor Conferences

Feb 10, 2021

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

Feb 4, 2021

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 10, 2021

Jan 6, 2021

Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer

Jan 4, 2021

Aethlon Medical to Present at the H.C. Wainwright BioConnect 2021 Conference

Dec 16, 2020

Aethlon Medical Announces First Patient Treated in First-in-Human Clinical Trial of HEMOPURIFIER® in Head and Neck Cancer

Nov 3, 2020

Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer

Oct 28, 2020

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

Oct 19, 2020

Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on October 28, 2020

Sep 9, 2020

Aethlon Medical to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...19
  • Facebook
  • Twitter
  • Linkedin
  • YouTube
Privacy Policy Disclaimer Sitemap
© 2021 Aethlon Medical, Inc. All Rights Reserved.